Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OnKure Therapeutics, Inc.RPHM · Entity 6550 | Chief Medical Officer | December 09, 2022 | December 13, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OnKure Therapeutics, Inc.
Report date December 09, 2022 · Filed December 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,000 |
Reported balance
After 2022-08-12 transaction · row 1
1 source rowRow 1 · 2022-08-12 · Gift · Disposed 22,348 · Balance 30,000 |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.80 · Expires 2032-12-08 | Direct | 125,000 |
Reported balance
After 2022-12-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-12-09 · Grant · Acquired 125,000 · Balance 125,000 F1: The shares vest in a series of 16 successive equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares vest in a series of 16 successive equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2022 Filed Dec 13, 2022 18:07 UTC | OnKure Therapeutics, Inc. RPHM · Entity 6550 | GrantStock option (right to buy) · Derivative | 125,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001209191-22-061032 · doc4.xml · derivative · entry 2 Dorenbaum Alejandro · CIK 0001606083 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2032-12-08 F1 · derivative.exercise_date: The shares vest in a series of 16 successive equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date. Read SEC document |
| August 12, 2022 Filed Dec 13, 2022 18:07 UTC | OnKure Therapeutics, Inc. RPHM · Entity 6550 | GiftCommon Stock | 22,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061032 · doc4.xml · nonDerivative · entry 1 Dorenbaum Alejandro · CIK 0001606083 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 16:30 UTC | OnKure Therapeutics, Inc. RPHM · Entity 6550 | GrantStock option (right to buy) · Derivative | 100,000 | $0.00 Strike: $6.69 | $0.00 |
DisclosureSEC source: 0001209191-21-069439 · doc4.xml · derivative · entry 2 Dorenbaum Alejandro · CIK 0001606083 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-12-09 F2 · derivative.exercise_date: The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Persons's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 16:30 UTC | OnKure Therapeutics, Inc. RPHM · Entity 6550 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-069439 · doc4.xml · nonDerivative · entry 1 Dorenbaum Alejandro · CIK 0001606083 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,348 F1 · shares: Represents a restricted stock unit award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.